UEG Week Recordings UEG Week Posters Online courses Guidelines Mistakes in... Podcasts Webinars
new
Gut Guide online
Visit ueg.eu Create myUEG account Log In
Visit ueg.eu Create myUEG account Log In

Filters:

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in imaging hepatic lesions and how to avoid them

Katja De Paepe

Summary

AI Generated

This article addresses eight common mistakes in the interpretation and acquisition of radiological images of incidental liver lesions, which are increasingly detected with cross-sectional imaging.

  • Incidental liver lesions encompass a large group of benign and malignant lesions, and combined use of different imaging modalities is often required for accurate diagnosis.
  • Clinicians and radiologists must be familiar with each imaging modality's strengths and limitations and aware of common pitfalls that can confound correct interpretation.
  • MRI plays an essential role in the characterisation of liver lesions, and a standard MRI protocol with sequence explanations is provided.
  • Recommendations for avoiding mistakes are based on clinical experience and literature where possible.
  • This material is most relevant for clinicians and radiologists involved in liver imaging interpretation.
Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8
1.
Lim, J. & Singal, A. G. Surveillance and Diagnosis of Hepatocellular Carcinoma. Clin. Liver Dis. 13, 2–5 (2019). [Link]
2.
Singal, A. G., Pillai, A. & Tiro, J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med. 11, e1001624 (2014) [Link]
3.
Tzartzeva, K. et al. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis. Gastroenterology 154, 1706-1718.e1 (2018). [Link]
4.
Simmons, O. et al. Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis. Aliment. Pharmacol. Ther. 45, 169–177 (2017) [Link]
5.
LI-RADS ® v2017 US Core. [Link]
6.
Vietti Violi, N., Fowler, K. J., Sirlin, C. B. & Taouli, B. Abbreviated Magnetic Resonance Imaging for HCC Surveillance. Clin. Liver Dis. 17, 133–138 (2021). [Link]
7.
Bedogni, G., Nobili, V. & Tiribelli, C. Epidemiology of fatty liver: an update. World J. Gastroenterol. 20, 9050–4 (2014). [Link]
8.
Vilgrain, V. et al. Hepatic steatosis: A major trap in liver imaging. Diagn. Interv. Imaging 94, 713–727 (2013) [Link]
9.
Jang, J. K., Jang, H. J., Kim, J. S. & Kim, T. K. Focal fat deposition in the liver: diagnostic challenges on imaging. Abdom. Radiol. 42, 1667–1678 (2017).
10.
CT/MRI Diagnostic Table [Link]
11.
Zane, K. E., Cloyd, J. M., Mumtaz, K. S., Wadhwa, V. & Makary, M. S. Metastatic disease to the liver: Locoregional therapy strategies and outcomes. World J. Clin. Oncol. 12, 725–745 (2021) [Link]
12.
Galle, P. R. et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma q. Journal of Hepatology 69, (2018) [Link]
13.
Alnammi, M., Wortman, J., Therrien, J. & Afnan, J. MRI features of treated hepatocellular carcinoma following locoregional therapy: a pictorial review. Abdom. Radiol. (New York) 47, 2299–2313 (2022) [Link]
14.
Brink, J. A. & Wagner, B. J. Pathways for the Spread of Disease in the Abdomen and Pelvis. in 57–65 (Springer, Cham, 2018). doi:10.1007/978-3-319-75019-4_6 [Link]
15.
Panagiotopoulou, P. B., Courcoutsakis, N., Tentes, A. & Prassopoulos, P. CT imaging of peritoneal carcinomatosis with surgical correlation: a pictorial review. Insights Imaging 12, 168 (2021). [Link]
16.
Sherif, A. M., Musa, E. R., Kedar, R. & Fu, L. Subcapsular hepatic endometriosis: case report and review of the literature. Radiol. case reports 11, 303–308 (2016). [Link]
17.
Ahlawat, S. et al. Magnetic resonance neurography of peripheral nerve tumors and tumorlike conditions. Neuroimaging Clin N Am. 24, 589–601 (2014). [Link]
18.
Schieda, N. et al. Renal and adrenal masses containing fat at MRI: Proposed nomenclature by the society of abdominal radiology disease-focused panel on renal cell carcinoma. J. Magn. Reson. Imaging 49, 917–926 (2019). [Link]
19.
Caseiro-Alves, F. et al. Liver haemangioma: common and uncommon findings and how to improve the differential diagnosis. Eur. Radiol. 17, 1544–1554 (2007). [Link]
20.
Vilgrain, V. et al. Imaging of Atypical Hemangiomas of the Liver with Pathologic Correlation. RadioGraphics 20, 379–397 (2000). [Link]
21.
Chen, L. et al. Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases. PLoS One 7, e48681 (2012). [Link]
22.
Doo, K. W. et al. ‘Pseudo washout’ sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor. AJR. Am. J. Roentgenol. 193, W490-6 (2009). [Link]
23.
Paulatto, L. et al. Colorectal liver metastases: radiopathological correlation. Insights Imaging 11, 99 (2020). [Link]
24.
Elsayes, K. M. et al. Spectrum of pitfalls, pseudolesions, and potential misdiagnoses in cirrhosis. Am. J. Roentgenol. 211, 87–96 (2018). [Link]

Abstract

Incidental liver lesions are increasingly found due to the incremental use of cross-sectional imaging. They encompass a large group of benign and malignant lesions, and the combined use of different imaging modalities is often required to make an accurate diagnosis. It is of utmost importance for clinicians and radiologists to be familiar with each imaging modality's strengths and limitations and be aware of common pitfalls that can confound the correct interpretation of findings. The article will discuss eight common mistakes in the interpretation and acquisition of radiological images. Recommendations on avoiding these mistakes will be based on clinical experience and literature where possible. As MRI plays an essential role in the characterisation of liver lesions, a standard MRI protocol with a brief explanation of the sequences has been added for reference

Topics

Hepatobiliary Radiology & Imaging

Citation

DePaepe K. Mistakes in imaging hepatic lesions and how to avoid them. UEG Education 2022; 22: 37-42.

Published

2022

More Like This:

Mistakes in the management of hepatocellular carcinoma and how to avoid them

Mistakes in the management of hepatocellular carcinoma and how to avoid them

Christos Triantos Christos Triantos, Ioannis Elefsiniotis, Spyridon Pantzios

Mistakes in endoscopic treatment of Barrett oesophagus neoplasia and how to avoid them

Mistakes in endoscopic treatment of Barrett oesophagus neoplasia and how to avoid them

Jacques J. Bergman Jacques J. Bergman, Roos E. Pouw, Eva Verheij

Weight loss "Endoscopy vs. Surgery" with Ivo Boskoski and Ralph Peterli

Weight loss "Endoscopy vs. Surgery" with Ivo Boskoski and Ralph Peterli

Ivo Boskoski Ivo Boskoski, Pradeep Mundre, Ralph Peterli

Management of duodenal adenomatosis in familial adenomatous polyposis patients

Management of duodenal adenomatosis in familial adenomatous polyposis patients

Elsa Soons Elsa Soons, Katarzyna Pawlak

Mistakes in bariatric surgery and how to avoid them

Mistakes in bariatric surgery and how to avoid them

Gianni Camerini Gianni Camerini, Francesco Saverio Papadia

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020

Cesare Hassan Cesare Hassan

UEG Mistakes In Articles
New
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in the management of hepatocellular carcinoma and how to avoid them

Spyridon Pantzios, Ioannis Elefsiniotis, Christos Triantos

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8
1.
Lim, J. & Singal, A. G. Surveillance and Diagnosis of Hepatocellular Carcinoma. Clin. Liver Dis. 13, 2–5 (2019). [Link]
2.
Singal, A. G., Pillai, A. & Tiro, J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med. 11, e1001624 (2014) [Link]
3.
Tzartzeva, K. et al. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis. Gastroenterology 154, 1706-1718.e1 (2018). [Link]
4.
Simmons, O. et al. Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis. Aliment. Pharmacol. Ther. 45, 169–177 (2017) [Link]
5.
LI-RADS ® v2017 US Core. [Link]
6.
Vietti Violi, N., Fowler, K. J., Sirlin, C. B. & Taouli, B. Abbreviated Magnetic Resonance Imaging for HCC Surveillance. Clin. Liver Dis. 17, 133–138 (2021). [Link]
7.
Bedogni, G., Nobili, V. & Tiribelli, C. Epidemiology of fatty liver: an update. World J. Gastroenterol. 20, 9050–4 (2014). [Link]
8.
Vilgrain, V. et al. Hepatic steatosis: A major trap in liver imaging. Diagn. Interv. Imaging 94, 713–727 (2013) [Link]
9.
Jang, J. K., Jang, H. J., Kim, J. S. & Kim, T. K. Focal fat deposition in the liver: diagnostic challenges on imaging. Abdom. Radiol. 42, 1667–1678 (2017).
10.
CT/MRI Diagnostic Table [Link]
11.
Zane, K. E., Cloyd, J. M., Mumtaz, K. S., Wadhwa, V. & Makary, M. S. Metastatic disease to the liver: Locoregional therapy strategies and outcomes. World J. Clin. Oncol. 12, 725–745 (2021) [Link]
12.
Galle, P. R. et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma q. Journal of Hepatology 69, (2018) [Link]
13.
Alnammi, M., Wortman, J., Therrien, J. & Afnan, J. MRI features of treated hepatocellular carcinoma following locoregional therapy: a pictorial review. Abdom. Radiol. (New York) 47, 2299–2313 (2022) [Link]
14.
Brink, J. A. & Wagner, B. J. Pathways for the Spread of Disease in the Abdomen and Pelvis. in 57–65 (Springer, Cham, 2018). doi:10.1007/978-3-319-75019-4_6 [Link]
15.
Panagiotopoulou, P. B., Courcoutsakis, N., Tentes, A. & Prassopoulos, P. CT imaging of peritoneal carcinomatosis with surgical correlation: a pictorial review. Insights Imaging 12, 168 (2021). [Link]
16.
Sherif, A. M., Musa, E. R., Kedar, R. & Fu, L. Subcapsular hepatic endometriosis: case report and review of the literature. Radiol. case reports 11, 303–308 (2016). [Link]
17.
Ahlawat, S. et al. Magnetic resonance neurography of peripheral nerve tumors and tumorlike conditions. Neuroimaging Clin N Am. 24, 589–601 (2014). [Link]
18.
Schieda, N. et al. Renal and adrenal masses containing fat at MRI: Proposed nomenclature by the society of abdominal radiology disease-focused panel on renal cell carcinoma. J. Magn. Reson. Imaging 49, 917–926 (2019). [Link]
19.
Caseiro-Alves, F. et al. Liver haemangioma: common and uncommon findings and how to improve the differential diagnosis. Eur. Radiol. 17, 1544–1554 (2007). [Link]
20.
Vilgrain, V. et al. Imaging of Atypical Hemangiomas of the Liver with Pathologic Correlation. RadioGraphics 20, 379–397 (2000). [Link]
21.
Chen, L. et al. Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases. PLoS One 7, e48681 (2012). [Link]
22.
Doo, K. W. et al. ‘Pseudo washout’ sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor. AJR. Am. J. Roentgenol. 193, W490-6 (2009). [Link]
23.
Paulatto, L. et al. Colorectal liver metastases: radiopathological correlation. Insights Imaging 11, 99 (2020). [Link]
24.
Elsayes, K. M. et al. Spectrum of pitfalls, pseudolesions, and potential misdiagnoses in cirrhosis. Am. J. Roentgenol. 211, 87–96 (2018). [Link]

Abstract

Liver cancer is the sixth most common cancer and the third leading cause of cancer-related death. Hepatocellular carcinoma (HCC) accounts for about 90% of cases and mostly arises in chronic liver disease, especially cirrhosis. Viral hepatitis remains a leading cause, but alcohol-related disease and MASLD are rising. With immune checkpoint inhibitors transforming HCC management, it is timely to highlight common mistakes across screening, staging, diagnosis and treatment.

Topics

Digestive Oncology Hepatobiliary

Published

2026

More Like This:

Mistakes in the management of hepatocellular carcinoma and how to avoid them

Mistakes in the management of hepatocellular carcinoma and how to avoid them

Christos Triantos Christos Triantos, Ioannis Elefsiniotis, Spyridon Pantzios

Mistakes in endoscopic treatment of Barrett oesophagus neoplasia and how to avoid them

Mistakes in endoscopic treatment of Barrett oesophagus neoplasia and how to avoid them

Jacques J. Bergman Jacques J. Bergman, Roos E. Pouw, Eva Verheij

Weight loss "Endoscopy vs. Surgery" with Ivo Boskoski and Ralph Peterli

Weight loss "Endoscopy vs. Surgery" with Ivo Boskoski and Ralph Peterli

Ivo Boskoski Ivo Boskoski, Pradeep Mundre, Ralph Peterli

Management of duodenal adenomatosis in familial adenomatous polyposis patients

Management of duodenal adenomatosis in familial adenomatous polyposis patients

Elsa Soons Elsa Soons, Katarzyna Pawlak

Mistakes in bariatric surgery and how to avoid them

Mistakes in bariatric surgery and how to avoid them

Gianni Camerini Gianni Camerini, Francesco Saverio Papadia

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020

Cesare Hassan Cesare Hassan

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in endoscopic treatment of Barrett oesophagus neoplasia and how to avoid them

Jacques J. Bergman, Roos E. Pouw, Eva Verheij

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8
1.
Lim, J. & Singal, A. G. Surveillance and Diagnosis of Hepatocellular Carcinoma. Clin. Liver Dis. 13, 2–5 (2019). [Link]
2.
Singal, A. G., Pillai, A. & Tiro, J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med. 11, e1001624 (2014) [Link]
3.
Tzartzeva, K. et al. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis. Gastroenterology 154, 1706-1718.e1 (2018). [Link]
4.
Simmons, O. et al. Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis. Aliment. Pharmacol. Ther. 45, 169–177 (2017) [Link]
5.
LI-RADS ® v2017 US Core. [Link]
6.
Vietti Violi, N., Fowler, K. J., Sirlin, C. B. & Taouli, B. Abbreviated Magnetic Resonance Imaging for HCC Surveillance. Clin. Liver Dis. 17, 133–138 (2021). [Link]
7.
Bedogni, G., Nobili, V. & Tiribelli, C. Epidemiology of fatty liver: an update. World J. Gastroenterol. 20, 9050–4 (2014). [Link]
8.
Vilgrain, V. et al. Hepatic steatosis: A major trap in liver imaging. Diagn. Interv. Imaging 94, 713–727 (2013) [Link]
9.
Jang, J. K., Jang, H. J., Kim, J. S. & Kim, T. K. Focal fat deposition in the liver: diagnostic challenges on imaging. Abdom. Radiol. 42, 1667–1678 (2017).
10.
CT/MRI Diagnostic Table [Link]
11.
Zane, K. E., Cloyd, J. M., Mumtaz, K. S., Wadhwa, V. & Makary, M. S. Metastatic disease to the liver: Locoregional therapy strategies and outcomes. World J. Clin. Oncol. 12, 725–745 (2021) [Link]
12.
Galle, P. R. et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma q. Journal of Hepatology 69, (2018) [Link]
13.
Alnammi, M., Wortman, J., Therrien, J. & Afnan, J. MRI features of treated hepatocellular carcinoma following locoregional therapy: a pictorial review. Abdom. Radiol. (New York) 47, 2299–2313 (2022) [Link]
14.
Brink, J. A. & Wagner, B. J. Pathways for the Spread of Disease in the Abdomen and Pelvis. in 57–65 (Springer, Cham, 2018). doi:10.1007/978-3-319-75019-4_6 [Link]
15.
Panagiotopoulou, P. B., Courcoutsakis, N., Tentes, A. & Prassopoulos, P. CT imaging of peritoneal carcinomatosis with surgical correlation: a pictorial review. Insights Imaging 12, 168 (2021). [Link]
16.
Sherif, A. M., Musa, E. R., Kedar, R. & Fu, L. Subcapsular hepatic endometriosis: case report and review of the literature. Radiol. case reports 11, 303–308 (2016). [Link]
17.
Ahlawat, S. et al. Magnetic resonance neurography of peripheral nerve tumors and tumorlike conditions. Neuroimaging Clin N Am. 24, 589–601 (2014). [Link]
18.
Schieda, N. et al. Renal and adrenal masses containing fat at MRI: Proposed nomenclature by the society of abdominal radiology disease-focused panel on renal cell carcinoma. J. Magn. Reson. Imaging 49, 917–926 (2019). [Link]
19.
Caseiro-Alves, F. et al. Liver haemangioma: common and uncommon findings and how to improve the differential diagnosis. Eur. Radiol. 17, 1544–1554 (2007). [Link]
20.
Vilgrain, V. et al. Imaging of Atypical Hemangiomas of the Liver with Pathologic Correlation. RadioGraphics 20, 379–397 (2000). [Link]
21.
Chen, L. et al. Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases. PLoS One 7, e48681 (2012). [Link]
22.
Doo, K. W. et al. ‘Pseudo washout’ sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor. AJR. Am. J. Roentgenol. 193, W490-6 (2009). [Link]
23.
Paulatto, L. et al. Colorectal liver metastases: radiopathological correlation. Insights Imaging 11, 99 (2020). [Link]
24.
Elsayes, K. M. et al. Spectrum of pitfalls, pseudolesions, and potential misdiagnoses in cirrhosis. Am. J. Roentgenol. 211, 87–96 (2018). [Link]

Abstract

Barrett’s oesophagus is a premalignant condition of the distal oesophagus predisposing to oesophageal adenocarcinoma. Given the potential for malignant progression and the poor prognosis of eosophageal adenocarcinoma when diagnosed at a symptomatic stage, patients with known Barrett oesophagus undergo regular endoscopic surveillance to detect neoplastic progression at an early and preferably endoscopically, treatable stage. Endoscopic management of early Barrett oesophagus neoplasia consists of a combination of endoscopic imaging, endoscopic resection and endoscopic ablation. Below we discuss a number of mistakes that are frequently made when managing Barrett oesophagus neoplasia and how to avoid them. Much of this discussion draws on existing guidelines (for background reading, check the ESGE Barrett oesophagus guideline), but in many instances the underlying evidence (even in the guideline) is missing and therefore many of our practically driven recommendations are based on common sense and our experience in this field.


Topics

Oesophagus

Citation

Verheij EPD, Pouw RE and Bergman JJ. Mistakes in endoscopic treatment of Barrett oesophagus neoplasia and how to avoid them. UEG Education 2021; 21: 35–39.

Published

2021

More Like This:

Mistakes in the management of hepatocellular carcinoma and how to avoid them

Mistakes in the management of hepatocellular carcinoma and how to avoid them

Christos Triantos Christos Triantos, Ioannis Elefsiniotis, Spyridon Pantzios

Mistakes in endoscopic treatment of Barrett oesophagus neoplasia and how to avoid them

Mistakes in endoscopic treatment of Barrett oesophagus neoplasia and how to avoid them

Jacques J. Bergman Jacques J. Bergman, Roos E. Pouw, Eva Verheij

Weight loss "Endoscopy vs. Surgery" with Ivo Boskoski and Ralph Peterli

Weight loss "Endoscopy vs. Surgery" with Ivo Boskoski and Ralph Peterli

Ivo Boskoski Ivo Boskoski, Pradeep Mundre, Ralph Peterli

Management of duodenal adenomatosis in familial adenomatous polyposis patients

Management of duodenal adenomatosis in familial adenomatous polyposis patients

Elsa Soons Elsa Soons, Katarzyna Pawlak

Mistakes in bariatric surgery and how to avoid them

Mistakes in bariatric surgery and how to avoid them

Gianni Camerini Gianni Camerini, Francesco Saverio Papadia

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020

Cesare Hassan Cesare Hassan

UEG Podcast Episode
UEG Podcast
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Weight loss "Endoscopy vs. Surgery" with Ivo Boskoski and Ralph Peterli

Ivo Boskoski, Ralph Peterli, Pradeep Mundre

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Topics

Endoscopy Surgery

Published

2024

More Like This:

Mistakes in the management of hepatocellular carcinoma and how to avoid them

Mistakes in the management of hepatocellular carcinoma and how to avoid them

Christos Triantos Christos Triantos, Ioannis Elefsiniotis, Spyridon Pantzios

Mistakes in endoscopic treatment of Barrett oesophagus neoplasia and how to avoid them

Mistakes in endoscopic treatment of Barrett oesophagus neoplasia and how to avoid them

Jacques J. Bergman Jacques J. Bergman, Roos E. Pouw, Eva Verheij

Weight loss "Endoscopy vs. Surgery" with Ivo Boskoski and Ralph Peterli

Weight loss "Endoscopy vs. Surgery" with Ivo Boskoski and Ralph Peterli

Ivo Boskoski Ivo Boskoski, Pradeep Mundre, Ralph Peterli

Management of duodenal adenomatosis in familial adenomatous polyposis patients

Management of duodenal adenomatosis in familial adenomatous polyposis patients

Elsa Soons Elsa Soons, Katarzyna Pawlak

Mistakes in bariatric surgery and how to avoid them

Mistakes in bariatric surgery and how to avoid them

Gianni Camerini Gianni Camerini, Francesco Saverio Papadia

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020

Cesare Hassan Cesare Hassan

UEG Podcast Episode
Journal Podcast
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Management of duodenal adenomatosis in familial adenomatous polyposis patients

Katarzyna Pawlak 1, Elsa Soons 2

Affiliations

1 Department Gastroenterology, Endoscopy Unit, Hospital of the Ministry of Interior and Administration, Szczecin, Poland

2 Radboud University Medical Center, Nijmegen, Netherlands

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Topics

Endoscopy

Published

2021

More Like This:

Mistakes in the management of hepatocellular carcinoma and how to avoid them

Mistakes in the management of hepatocellular carcinoma and how to avoid them

Christos Triantos Christos Triantos, Ioannis Elefsiniotis, Spyridon Pantzios

Mistakes in endoscopic treatment of Barrett oesophagus neoplasia and how to avoid them

Mistakes in endoscopic treatment of Barrett oesophagus neoplasia and how to avoid them

Jacques J. Bergman Jacques J. Bergman, Roos E. Pouw, Eva Verheij

Weight loss "Endoscopy vs. Surgery" with Ivo Boskoski and Ralph Peterli

Weight loss "Endoscopy vs. Surgery" with Ivo Boskoski and Ralph Peterli

Ivo Boskoski Ivo Boskoski, Pradeep Mundre, Ralph Peterli

Management of duodenal adenomatosis in familial adenomatous polyposis patients

Management of duodenal adenomatosis in familial adenomatous polyposis patients

Elsa Soons Elsa Soons, Katarzyna Pawlak

Mistakes in bariatric surgery and how to avoid them

Mistakes in bariatric surgery and how to avoid them

Gianni Camerini Gianni Camerini, Francesco Saverio Papadia

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020

Cesare Hassan Cesare Hassan

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in bariatric surgery and how to avoid them

Francesco Saverio Papadia, Gianni Camerini

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

References

Mistakes
References
Mistake 1 Mistake 2 Mistake 3 Mistake 4 Mistake 5 Mistake 6 Mistake 7 Mistake 8
1.
Lim, J. & Singal, A. G. Surveillance and Diagnosis of Hepatocellular Carcinoma. Clin. Liver Dis. 13, 2–5 (2019). [Link]
2.
Singal, A. G., Pillai, A. & Tiro, J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med. 11, e1001624 (2014) [Link]
3.
Tzartzeva, K. et al. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis. Gastroenterology 154, 1706-1718.e1 (2018). [Link]
4.
Simmons, O. et al. Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis. Aliment. Pharmacol. Ther. 45, 169–177 (2017) [Link]
5.
LI-RADS ® v2017 US Core. [Link]
6.
Vietti Violi, N., Fowler, K. J., Sirlin, C. B. & Taouli, B. Abbreviated Magnetic Resonance Imaging for HCC Surveillance. Clin. Liver Dis. 17, 133–138 (2021). [Link]
7.
Bedogni, G., Nobili, V. & Tiribelli, C. Epidemiology of fatty liver: an update. World J. Gastroenterol. 20, 9050–4 (2014). [Link]
8.
Vilgrain, V. et al. Hepatic steatosis: A major trap in liver imaging. Diagn. Interv. Imaging 94, 713–727 (2013) [Link]
9.
Jang, J. K., Jang, H. J., Kim, J. S. & Kim, T. K. Focal fat deposition in the liver: diagnostic challenges on imaging. Abdom. Radiol. 42, 1667–1678 (2017).
10.
CT/MRI Diagnostic Table [Link]
11.
Zane, K. E., Cloyd, J. M., Mumtaz, K. S., Wadhwa, V. & Makary, M. S. Metastatic disease to the liver: Locoregional therapy strategies and outcomes. World J. Clin. Oncol. 12, 725–745 (2021) [Link]
12.
Galle, P. R. et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma q. Journal of Hepatology 69, (2018) [Link]
13.
Alnammi, M., Wortman, J., Therrien, J. & Afnan, J. MRI features of treated hepatocellular carcinoma following locoregional therapy: a pictorial review. Abdom. Radiol. (New York) 47, 2299–2313 (2022) [Link]
14.
Brink, J. A. & Wagner, B. J. Pathways for the Spread of Disease in the Abdomen and Pelvis. in 57–65 (Springer, Cham, 2018). doi:10.1007/978-3-319-75019-4_6 [Link]
15.
Panagiotopoulou, P. B., Courcoutsakis, N., Tentes, A. & Prassopoulos, P. CT imaging of peritoneal carcinomatosis with surgical correlation: a pictorial review. Insights Imaging 12, 168 (2021). [Link]
16.
Sherif, A. M., Musa, E. R., Kedar, R. & Fu, L. Subcapsular hepatic endometriosis: case report and review of the literature. Radiol. case reports 11, 303–308 (2016). [Link]
17.
Ahlawat, S. et al. Magnetic resonance neurography of peripheral nerve tumors and tumorlike conditions. Neuroimaging Clin N Am. 24, 589–601 (2014). [Link]
18.
Schieda, N. et al. Renal and adrenal masses containing fat at MRI: Proposed nomenclature by the society of abdominal radiology disease-focused panel on renal cell carcinoma. J. Magn. Reson. Imaging 49, 917–926 (2019). [Link]
19.
Caseiro-Alves, F. et al. Liver haemangioma: common and uncommon findings and how to improve the differential diagnosis. Eur. Radiol. 17, 1544–1554 (2007). [Link]
20.
Vilgrain, V. et al. Imaging of Atypical Hemangiomas of the Liver with Pathologic Correlation. RadioGraphics 20, 379–397 (2000). [Link]
21.
Chen, L. et al. Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases. PLoS One 7, e48681 (2012). [Link]
22.
Doo, K. W. et al. ‘Pseudo washout’ sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor. AJR. Am. J. Roentgenol. 193, W490-6 (2009). [Link]
23.
Paulatto, L. et al. Colorectal liver metastases: radiopathological correlation. Insights Imaging 11, 99 (2020). [Link]
24.
Elsayes, K. M. et al. Spectrum of pitfalls, pseudolesions, and potential misdiagnoses in cirrhosis. Am. J. Roentgenol. 211, 87–96 (2018). [Link]

Abstract

Nowadays, obesity represents an immense burden for global healthcare. The number of overweight or obese cases has exceeded that of underweight individuals.1 Bariatric surgery is accepted as a safe and effective treatment for patients with morbid obesity and has gained widespread popularity in the past two decades. Advancements in surgical techniques, perioperative care, and fellowship-based bariatric surgery training have substantially reduced morbidity and mortality rates. Nevertheless, several controversial aspects of surgical treatments of morbidly obese patients are still to be considered. Here we discuss the mistakes made when managing patients who are candidates for or have been submitted to bariatric surgery in the preoperative, perioperative, and postoperative periods. As high-level evidence is lacking for many aspects of surgical bariatric care, the discussion is based on our long-standing clinical experience.


Topics

Primary Care Small Intestine & Nutrition Surgery

Citation

Papadia Saverio F and Camerini G. Mistakes in bariatric surgery and how to avoid them. UEG Education 2022; 22: 11–15.

Published

2022

More Like This:

Mistakes in the management of hepatocellular carcinoma and how to avoid them

Mistakes in the management of hepatocellular carcinoma and how to avoid them

Christos Triantos Christos Triantos, Ioannis Elefsiniotis, Spyridon Pantzios

Mistakes in endoscopic treatment of Barrett oesophagus neoplasia and how to avoid them

Mistakes in endoscopic treatment of Barrett oesophagus neoplasia and how to avoid them

Jacques J. Bergman Jacques J. Bergman, Roos E. Pouw, Eva Verheij

Weight loss "Endoscopy vs. Surgery" with Ivo Boskoski and Ralph Peterli

Weight loss "Endoscopy vs. Surgery" with Ivo Boskoski and Ralph Peterli

Ivo Boskoski Ivo Boskoski, Pradeep Mundre, Ralph Peterli

Management of duodenal adenomatosis in familial adenomatous polyposis patients

Management of duodenal adenomatosis in familial adenomatous polyposis patients

Elsa Soons Elsa Soons, Katarzyna Pawlak

Mistakes in bariatric surgery and how to avoid them

Mistakes in bariatric surgery and how to avoid them

Gianni Camerini Gianni Camerini, Francesco Saverio Papadia

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020

Cesare Hassan Cesare Hassan

UEG Standards and Guidelines
Clinical Practice Guideline
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020

Cesare Hassan

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Guideline

Main recommendations

The following recommendations for post-polypectomy colonoscopic surveillance apply to all patients who had one or more polyps that were completely removed during a high quality baseline colonoscopy.

1 ESGE recommends that patients with complete removal of 1 – 4 < 10 mm adenomas with low grade dysplasia, irrespective of villous components, or any serrated polyp < 10mm without dysplasia, do not require endoscopic surveillance and should be returned to screening.

Strong recommendation, moderate quality evidence.

If organized screening is not available, repetition of colonoscopy 10 years after the index procedure is recommended.

Strong recommendation, moderate quality evidence.

2 ESGE recommends surveillance colonoscopy after 3 years for patients with complete removal of at least 1 adenoma >= 10mm or with high grade dysplasia, or >=5 adenomas, or any serrated polyp >= 10mm or with dysplasia.

Strong recommendation, moderate quality evidence.

3 ESGE recommends a 3 – 6-month early repeat colonoscopy following piecemeal endoscopic resection of polyps >= 20mm.

Strong recommendation, moderate quality evidence.

A first surveillance colonoscopy 12 months after the repeat colonoscopy is recommended to detect late recurrence. Strong recommendation, high quality evidence.

4 If no polyps requiring surveillance are detected at the first surveillance colonoscopy, ESGE suggests to perform a second surveillance colonoscopy after 5 years. Weak recommendation, low quality evidence. After that, if no polyps requiring surveillance are detected, patients can be returned to screening.

5 ESGE suggests that, if polyps requiring surveillance are detected at first or subsequent surveillance examinations, surveillance colonoscopy may be performed at 3 years.

Weak recommendation, low quality evidence.

A flowchart showing the recommended surveillance intervals is provided (Fig. 1).

Publisher

European Society of Gastrointestinal Endoscopy logo
European Society of Gastrointestinal Endoscopy

Guideline

Clinical Practice Guideline

Topics

Endoscopy

Citation

Endoscopy. 2020 Jun 22

Published

2020

More Like This:

Mistakes in the management of hepatocellular carcinoma and how to avoid them

Mistakes in the management of hepatocellular carcinoma and how to avoid them

Christos Triantos Christos Triantos, Ioannis Elefsiniotis, Spyridon Pantzios

Mistakes in endoscopic treatment of Barrett oesophagus neoplasia and how to avoid them

Mistakes in endoscopic treatment of Barrett oesophagus neoplasia and how to avoid them

Jacques J. Bergman Jacques J. Bergman, Roos E. Pouw, Eva Verheij

Weight loss &quot;Endoscopy vs. Surgery&quot; with Ivo Boskoski and Ralph Peterli

Weight loss &quot;Endoscopy vs. Surgery&quot; with Ivo Boskoski and Ralph Peterli

Ivo Boskoski Ivo Boskoski, Pradeep Mundre, Ralph Peterli

Management of duodenal adenomatosis in familial adenomatous polyposis patients

Management of duodenal adenomatosis in familial adenomatous polyposis patients

Elsa Soons Elsa Soons, Katarzyna Pawlak

Mistakes in bariatric surgery and how to avoid them

Mistakes in bariatric surgery and how to avoid them

Gianni Camerini Gianni Camerini, Francesco Saverio Papadia

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020

Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020

Cesare Hassan Cesare Hassan

The global reference point for the digestive health community

Platform Publisher

United European Gastroenterology

Wickenburggasse 1 1080 Vienna, Austria

Contact us

support@ueg.eu

ueg.eu

T: +43 1 997 1639

Legal

Terms & Conditions

Imprint

Privacy Policy

Explore

My Bookmarks

My recommendations

My fields of interest

© 2026 United European Gastroenterology

Change fields of interest

These fields are selected based on the interests in your myUEG profile.
Click the item to unselect it. You can select multiple items.